Treatments For Epilepsy And Symptoms Of Slc13a5 Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2015 | 41,725 | 20,204 | 21,521 | 12.8 | — |
| 2016 | 211,284 | 84,989 | 126,295 | 20.9 | 0% |
| 2017 | 185,768 | 248,656 | −62,888 | 4.1 | 0% |
| 2018 | 286,889 | 172,923 | 113,966 | 13.8 | 0% |
| 2019 | 392,669 | 368,510 | 24,159 | 7.3 | 0% |
| 2020 | 675,901 | 113,779 | 562,122 | 82.8 | 18% |
| 2021 | 381,268 | 466,822 | −85,554 | 18.0 | 22% |
| 2022 | 610,734 | 868,351 | −257,617 | 6.1 | 23% |
| 2023 | 503,647 | 497,687 | 5,960 | 10.8 | 51% |
In its most recent public year (2023), this organization brought in $5,960 more than it spent. Its reserves stood at about 10.8 months of spending, down from 12.8 in 2015. Staff pay was 51% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Treatments For Epilepsy And Symptoms Of Slc13a5 Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works